Isoalantolactone (IAL) Regulates Neuro-Inflammation and Neuronal Apoptosis to Curb Pathology of Parkinson’s Disease
Open Access
Abstract
Parkinson’s disease (PD) is a neurodegenerative disease in which neuronal apoptosis and associated inflammation are involved in its pathogenesis. However, there is still no specific treatment that can stop PD progression. Isoalantolactone (IAL) plays a role in many inflammation-related diseases. However, its effect and mechanism in PD remain unclear. In this study, results showed that IAL administration ameliorated 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-induced PD-related pathological impairment and decreased motor activity in mice. Results from in vitro mechanistic studies showed that IAL regulated apoptosis-related proteins by activating the AKT/Nrf2 pathway, thereby suppressing the apoptosis of SN4741 cells induced by N-methyl-4-phenylpyridinium Iodide (MPP+). On the other hand, IAL inhibited LPS-induced release of pro-inflammatory mediators in BV2 cells by activating the AKT/Nrf2/HO-1 pathway and inhibiting the NF-κB pathway. In addition, IAL protected SN4741 from microglial activation-mediated neurotoxicity. Taken together, these results highlight the beneficial role of IAL as a novel therapy and potential PD drug due to its pharmacological profile.Keywords
Funding Information
- Fundamental Research Funds for the Central Universities (2021JCKT-06, 202210183336, 202210183317)
- College Students Innovation and Entrepreneurship Training Program of Jilin University (2021JCKT-06, 202210183336, 202210183317)
This publication has 51 references indexed in Scilit:
- Dietary Factors in the Etiology of Parkinson’s DiseaseBioMed Research International, 2015
- Protective effects of Gynostemma pentaphyllum polysaccharides on PC12 cells impaired by MPP+International Journal of Biological Macromolecules, 2014
- Isoalantolactone from Inula helenium Caused Nrf2-Mediated Induction of Detoxifying EnzymesJournal of Medicinal Food, 2009
- AKT/PKB Signaling: Navigating DownstreamCell, 2007
- Heme oxygenase‐1 (HO‐1) inhibits postmyocardial infarct remodeling and restores ventricular functionThe FASEB Journal, 2006
- Dopaminergic neuronsThe International Journal of Biochemistry & Cell Biology, 2005
- Clinical differentiation of parkinsonian syndromes: Prognostic and therapeutic relevanceThe American Journal of Medicine, 2004
- Nrf2 signaling in coordinated activation of antioxidant gene expressionFree Radical Biology and Medicine, 2004
- Parkinson's DiseaseNeuron, 2003
- Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidaseBiochemical and Biophysical Research Communications, 1984